Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)
Clinical trial NCT00561080 · COMPLETED
Trial details
- NCT number
- NCT00561080
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-26
- Primary completion
- 2009-06-03
- Enrollment
- 759
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.